Cargando…
Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic Plasmodium falciparum infection
BACKGROUND: The development and spread of drug resistant Plasmodium falciparum strains is a major concern and novel anti-malarial drugs are, therefore, needed. Ferroquine is a ferrocenic derivative of chloroquine with proven anti-malarial activity against chloroquine-resistant and -sensitive P. falc...
Autores principales: | Mombo-Ngoma, Ghyslain, Supan, Christian, Dal-Bianco, Matthias P, Missinou, Michel A, Matsiegui, Pierre-Blaise, Ospina Salazar, Carmen L, Issifou, Saadou, Ter-Minassian, Daniel, Ramharter, Michael, Kombila, Maryvonne, Kremsner, Peter G, Lell, Bertrand |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056844/ https://www.ncbi.nlm.nih.gov/pubmed/21362162 http://dx.doi.org/10.1186/1475-2875-10-53 |
Ejemplares similares
-
Antipyretic effect of ibuprofen in Gabonese children with uncomplicated falciparum malaria: a randomized, double-blind, placebo-controlled trial
por: Matsiégui, Pierre-Blaise, et al.
Publicado: (2008) -
Real-life effectiveness of anti-malarial treatment regimens: what are we aiming for?
por: Mbassi, Dorothea Ekoka, et al.
Publicado: (2023) -
A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon
por: Frank, Matthias, et al.
Publicado: (2011) -
Malaria in pregnancy in rural Gabon: a cross-sectional survey on the impact of seasonality in high-risk groups
por: Jäckle, Mario J, et al.
Publicado: (2013) -
The antimalarial ferroquine: from bench to clinic
por: Biot, C., et al.
Publicado: (2011)